SCHEMBL6018445

SCHEMBL6018445

CC(=O)NNC(=O)CCCCC(=O)N(N)C(C)=O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 5/20 0.40
MAPT P10636 3/20 0.40
KDM4E B2RXH2 1/20 0.40
TDP1 Q9NUW8 1/20 0.34
ALDH1A1 P00352 2/20 0.32
LMNA P02545 1/20 0.32
MEN1 O00255 4/20 0.32
NPSR1 Q6W5P4 1/20 0.32
ALPL P05186 2/20 0.31
ALPI P09923 1/20 0.31
ALPG P10696 1/20 0.31
HDAC3 O15379 1/20 0.30
HDAC1 Q13547 1/20 0.30
HDAC2 Q92769 1/20 0.30
HDAC8 Q9BY41 1/20 0.30
HDAC6 Q9UBN7 1/20 0.30
HDAC5 Q9UQL6 1/20 0.30
POLB P06746 1/20 0.30
BLM P54132 1/20 0.30
CTDSP1 Q9GZU7 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL549433 0.82 LMNA (0.39) ALDH1A1LMNAHDAC1HDAC2HDAC6
SCHEMBL8724482 0.81 CTSD (0.43) MAPTKDM4EALDH1A1LMNAHDAC3
SCHEMBL11681111 0.80 PAOX (0.41) ALDH1A1LMNAHDAC1HDAC2HDAC6
SCHEMBL12155314 0.80 KMT2A (0.53) KMT2AMAPTKDM4ETDP1ALDH1A1
SCHEMBL6127991 0.75 CTSD (0.48) KMT2AMAPTKDM4ETDP1ALDH1A1
SCHEMBL11311134 0.73 ALDH1A1 (0.35) ALDH1A1LMNABLM
SCHEMBL5802104 0.72 ALDH1A1 (0.54) KMT2ATDP1ALDH1A1LMNAMEN1
SCHEMBL3933329 0.72 KMT2A (0.67) KMT2AMAPTKDM4EALDH1A1MEN1
SCHEMBL14189780 0.72 KMT2A (0.47) KMT2AMAPTKDM4ETDP1ALDH1A1
SCHEMBL8745827 0.71 KMT2A (0.65) KMT2AMAPTKDM4ETDP1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060173107-A1 Graftable hindered amine light stabilizers CIBA SPECIALTY CHEMICALS CORP. 2006-08-03 US disclosed
US-20030191242-A1 Romp with oligomeric uv-absorbers CIBA SPECIALTY CHEMICALS CORP. 2003-10-09 US disclosed
EP-1263833-A1 ROMP WITH OLIGOMERIC UV-ABSORBERS Ciba SC Holding AG (CH) 2002-12-11 EP disclosed
WO-2001062821-A1 ROMP WITH OLIGOMERIC UV-ABSORBERS CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) 2001-08-30 WO disclosed
US-6028131-A Antioxidants containing phenol groups and aromatic amine groups CIBA SPECIALTY CHEMICALS CORPORATION (US) 2000-02-22 US disclosed
US-4125533-A STABILIZERS SANKYO CO. LTD. (JP) 1978-11-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060173107-A1 Graftable hindered amine light stabilizers IDO1, MAOA, TPH1 KMT2A 744/4885MAPT 126/4885KDM4E 1124/4885
US-20030191242-A1 Romp with oligomeric uv-absorbers OSTC, OCIAD1, OCIAD2 KMT2A 4216/4885MAPT 473/4885KDM4E 4192/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.